$WDLF
Decentral Life Inc

2023 Q3 Form 10-Q Financial Statement

#000149315223029508 Filed on August 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $173.2K $173.2K $140.0K
YoY Change -66.15% 23.71% 55.56%
Cost Of Revenue $28.04K
YoY Change
Gross Profit $173.2K $145.1K $140.0K
YoY Change -66.15% 3.68% 72.6%
Gross Profit Margin 100.0% 83.81% 100.0%
Selling, General & Admin $260.0K $162.9K $75.63K
YoY Change 364.53% 115.36% -55.52%
% of Gross Profit 150.14% 112.21% 54.02%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $260.0K $162.9K $75.63K
YoY Change 364.54% 115.36% -57.7%
Operating Profit -$86.83K -$17.73K $64.37K
YoY Change -119.06% -127.54% -165.91%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.00 $6.00 -$5.126K
YoY Change -100.0% -100.12%
Pretax Income -$86.83K -$17.72K $59.24K
YoY Change -117.8% -129.91% -160.66%
Income Tax
% Of Pretax Income
Net Earnings -$86.83K -$17.72K $59.24K
YoY Change -117.8% -129.91% -160.66%
Net Earnings / Revenue -50.14% -10.23% 42.32%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $7.72
COMMON SHARES
Basic Shares Outstanding 7.395B shares 7.395B shares 7.675B shares
Diluted Shares Outstanding 7.395B shares 7.675B shares 7.675B shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change -100.0%
Cash & Equivalents $77.91K $31.34K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables $592.5K
Total Short-Term Assets $643.3K $641.9K $423.1K
YoY Change -25.63% 51.74% -9.67%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $643.3K $641.9K $423.1K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $643.3K $641.9K $423.1K
YoY Change -25.63% 51.74% -9.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $52.35K
YoY Change -52.43%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $170.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $90.00K $52.53K
YoY Change 77.44% -52.27%
LONG-TERM LIABILITIES
Long-Term Debt $495.4K
YoY Change 48.52%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $495.4K
YoY Change 48.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $90.00K $52.53K
Total Long-Term Liabilities $495.4K
Total Liabilities $207.5K $119.3K $547.9K
YoY Change -58.67% -78.23% 23.52%
SHAREHOLDERS EQUITY
Retained Earnings -$32.95M -$32.86M -$33.51M
YoY Change -0.22% -1.93%
Common Stock $33.39M $33.39M $33.39M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $435.8K $522.6K -$124.9K
YoY Change
Total Liabilities & Shareholders Equity $643.3K $641.9K $423.1K
YoY Change -25.63% 51.74% -9.67%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$86.83K -$17.72K $59.24K
YoY Change -117.8% -129.91% -160.66%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $48.37K -$124.7K $1.320K
YoY Change -87.48% -9546.97% -101.32%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.800K -13.07K -1.540K
YoY Change -31.03% 748.7% -408.0%
NET CHANGE
Cash From Operating Activities 48.37K -124.7K 1.320K
Cash From Investing Activities
Cash From Financing Activities -1.800K -13.07K -1.540K
Net Change In Cash 46.57K -137.8K -220.0
YoY Change -87.86% 62522.73% -99.78%
FREE CASH FLOW
Cash From Operating Activities $48.37K -$124.7K $1.320K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001281984
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q2 us-gaap Loans Payable
LoansPayable
usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55961
dei Entity Registrant Name
EntityRegistrantName
Decentral Life, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-0495298
dei Entity Address Address Line1
EntityAddressAddressLine1
6400 S. Fiddlers Green Circle
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1180
dei Entity Address City Or Town
EntityAddressCityOrTown
Greenwood Village
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80111
dei City Area Code
CityAreaCode
(855)
dei Local Phone Number
LocalPhoneNumber
933-3277
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7394792892 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31338 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
199310 usd
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
592488 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
628238 usd
CY2023Q2 WDLF Security Deposits
SecurityDeposits
18118 usd
CY2022Q4 WDLF Security Deposits
SecurityDeposits
18118 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
641944 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
845666 usd
CY2023Q2 us-gaap Assets
Assets
641944 usd
CY2022Q4 us-gaap Assets
Assets
845666 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
720 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
129673 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
130393 usd
CY2023Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
119300 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
121700 usd
CY2023Q2 us-gaap Liabilities
Liabilities
119300 usd
CY2022Q4 us-gaap Liabilities
Liabilities
252093 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7394792892 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7394792892 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7394792892 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7394792892 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
7394793 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
7394793 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
25992306 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
25992306 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32864455 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32793526 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
522644 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
593573 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
641944 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
845666 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
173188 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
315963 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140000 usd
CY2023Q2 us-gaap Revenues
Revenues
173188 usd
CY2022Q2 us-gaap Revenues
Revenues
140000 usd
us-gaap Revenues
Revenues
315963 usd
us-gaap Revenues
Revenues
140000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28038 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
44215 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
145149 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
140000 usd
us-gaap Gross Profit
GrossProfit
271748 usd
us-gaap Gross Profit
GrossProfit
140000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
31040 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2140 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
41421 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4956 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
131836 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
73490 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
301272 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
120972 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
162876 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
75630 usd
us-gaap Operating Expenses
OperatingExpenses
342693 usd
us-gaap Operating Expenses
OperatingExpenses
125929 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-17727 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
64370 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-70945 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
14071 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5126 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5126 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5126 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
16 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5126 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-17721 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
59244 usd
us-gaap Net Income Loss
NetIncomeLoss
-70929 usd
us-gaap Net Income Loss
NetIncomeLoss
8946 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7675367567 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7675367567 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7675367567 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7675367567 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7675367567 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7675367567 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7675367567 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7675367567 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-133813 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-50299 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-184111 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
59244 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-124867 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
593573 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
593573 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-53208 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
540364 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
540364 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-17721 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
522644 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
522644 usd
us-gaap Net Income Loss
NetIncomeLoss
-70929 usd
us-gaap Net Income Loss
NetIncomeLoss
8946 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-173 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-35750 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
15050 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-720 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35899 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5931 usd
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
2400 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
5155 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
129673 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-132073 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5155 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-167972 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-776 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
199310 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
776 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31338 usd
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000000 shares
CY2023Q2 us-gaap Common Stock Voting Rights
CommonStockVotingRights
vote of stockholders holding over 51% of the Company’s voting power
CY2023Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
Common Stock at a range from 100 to 1 up to 50,000 to 1
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zVW2fmjGB1wc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_869_zCSHo9NhsAn8">Use of estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated useful lives of property and equipment. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zXsvkfpE8Cw1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86D_zgf8m6Kgvo89">Concentrations of Credit Risk</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. The Company continually monitors its banking relationships and consequently have not experienced any losses in its accounts. The Company is not exposed to any significant credit risk on cash.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
31338 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
199310 usd
CY2018Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2020Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q2 us-gaap Cash
Cash
31338 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32864455 usd
us-gaap Net Income Loss
NetIncomeLoss
-70929 usd
us-gaap Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
since January 1, 2021, or currently proposed transaction, in which the Company was or is to be a participant and the amount involved exceeds $5,000 or one percent of our total assets at June 30, 2023, and in which any of the following persons had or will have a direct or indirect material interest
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares

Files In Submission

Name View Source Status
0001493152-23-029508-index-headers.html Edgar Link pending
0001493152-23-029508-index.html Edgar Link pending
0001493152-23-029508.txt Edgar Link pending
0001493152-23-029508-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wdlf-20230630.xsd Edgar Link pending
wdlf-20230630_def.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
wdlf-20230630_cal.xml Edgar Link unprocessable
wdlf-20230630_lab.xml Edgar Link unprocessable
wdlf-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable